PRODUCT DETAILS

  OXRA MET 5MG/1000MG TABLETS | Dapagliflozin Metformin Guide

 OXRA MET 5MG/1000MG TABLETS contain Dapagliflozin 5mg and Metformin 1000mg, a combination therapy prescribed for type 2 diabetes management to improve blood glucose control.

 OXRA MET 5MG/1000MG TABLETS

OXRA MET 5MG/1000MG TABLETS (DAPAGLIFLOZIN 5MG + METFORMIN 1000MG): Comprehensive Guide and Benefits

Introduction to OXRA MET 5MG/1000MG TABLETS

OXRA MET 5MG/1000MG: Dual-Action Diabetes Management Therapy

OXRA MET 5MG/1000MG TABLETS contain a combination of two antidiabetic medicines: Dapagliflozin 5mg and Metformin 1000mg. It belongs to the SGLT2 inhibitor + Biguanide antidiabetic class and is prescribed for improving blood glucose control in adults with type 2 diabetes mellitus when combination therapy is appropriate.

This combination works through two complementary mechanisms: Dapagliflozin helps remove excess glucose through urine, while Metformin reduces glucose production in the liver and improves insulin sensitivity. OXRA MET is a prescription-only medicine and should be taken under medical supervision.

Key Benefits of OXRA MET 5MG/1000MG TABLETS

Helps improve blood glucose control in adults with type 2 diabetes.

Combines two medicines with different glucose-lowering mechanisms.

Supports reduction of excess glucose through urinary elimination.

Helps improve insulin sensitivity and reduce liver glucose production.

May reduce the risk of diabetes-related complications when used as part of a complete diabetes management plan. 

How OXRA MET 5MG/1000MG TABLETS Works

OXRA MET contains two active ingredients:

1. Dapagliflozin 5MG

Dapagliflozin is an SGLT2 inhibitor that blocks sodium-glucose cotransporter-2 in the kidneys. This reduces glucose reabsorption and allows excess glucose to be removed through urine, helping lower blood sugar levels.

2. Metformin 1000MG

Metformin belongs to the biguanide class. It helps reduce glucose production by the liver, improves insulin sensitivity, and supports better utilization of glucose by body tissues.

Together, these medicines provide complementary glucose-lowering effects for type 2 diabetes management.

Usage Instructions for OXRA MET 5MG/1000MG TABLETS

Take OXRA MET exactly as prescribed by your doctor.

Swallow the tablet whole with water.

Take it with or after food to reduce stomach-related discomfort unless otherwise advised.

Take the medicine at the same time each day.

Do not stop treatment without consulting your healthcare provider.

Regular monitoring of blood glucose and kidney function may be required. 

Medicinal Advantages of OXRA MET 5MG/1000MG TABLETS

Provides dual-action control of elevated blood glucose.

Helps manage type 2 diabetes in patients requiring combination therapy.

Supports improved insulin response through Metformin action.

Helps remove excess glucose through the kidneys via Dapagliflozin.

May support cardiovascular and kidney health benefits in suitable patients as determined by a doctor. 

Note: OXRA MET should be used along with a healthy diet, regular physical activity, and medical follow-up as recommended by your healthcare provider.

Off-Label Uses of OXRA MET 5MG/1000MG TABLETS

Dapagliflozin and Metformin combinations may be evaluated by specialists for additional applications based on clinical evidence and patient-specific requirements.

Possible specialist-guided uses may include:

Individualized metabolic management strategies.

Additional cardiovascular or kidney-related approaches where medically appropriate.

Disclaimer: Off-label use should only be considered under qualified medical supervision.

Expert Advice for Optimal Use

Follow your prescribed dose schedule carefully.

Maintain adequate hydration unless fluid restriction is advised.

Monitor blood sugar levels regularly.

Inform your doctor before surgery or prolonged fasting.

Avoid excessive alcohol consumption.

Report symptoms such as severe weakness, dehydration, unusual breathing difficulty, or persistent stomach discomfort.

Precautions

Kidney Function

Kidney function should be assessed before and during treatment because both Dapagliflozin and Metformin require careful evaluation in patients with kidney impairment.

Liver Function

Inform your doctor if you have liver disease before starting treatment.

Pregnancy & Breastfeeding

Consult your healthcare provider before using OXRA MET during pregnancy or breastfeeding.

Drug Interactions

Inform your doctor about all medicines, including:

Other diabetes medicines

Insulin therapy

Diuretics (water tablets)

Blood pressure medicines

Kidney-affecting medicines

Alcohol-containing products

Existing Medical Conditions

Tell your doctor if you have:

Kidney disease

Liver disease

Heart conditions

Dehydration problems

History of diabetic ketoacidosis

Frequent urinary or genital infections

Storage Instructions

Store below 30°C.

Keep tablets in the original blister packaging.

Protect from moisture and direct sunlight.

Keep away from children.

Do not use after the expiry date.

Frequently Asked Questions (FAQs)

Q: What is OXRA MET 5MG/1000MG TABLETS used for?

A: OXRA MET 5MG/1000MG TABLETS are used for managing type 2 diabetes mellitus by combining Dapagliflozin and Metformin to improve blood sugar control.

Q: What are the active ingredients in OXRA MET 5MG/1000MG?

A: The active ingredients are Dapagliflozin 5mg and Metformin 1000mg.

Q: Is OXRA MET an insulin medicine?

A: No. OXRA MET does not contain insulin. It works by improving glucose control through kidney glucose removal and improved insulin sensitivity.

Q: Can OXRA MET be taken without a prescription?

A: No. OXRA MET is a prescription medicine and should be taken only under medical supervision.

Q: What are common side effects of OXRA MET?

A: Possible side effects may include diarrhea, nausea, stomach discomfort, increased urination, urinary tract infections, and genital fungal infections.

Q: How should OXRA MET 5MG/1000MG be taken?

A: It should be taken according to your doctor’s instructions, usually with or after food, and swallowed whole with water.

Product Tags

OXRA MET 5MG/1000MG TABLETS, Dapagliflozin 5mg Metformin 1000mg, Dapagliflozin Metformin Tablet, SGLT2 Inhibitor, Biguanide Medicine, Type 2 Diabetes Medicine, Antidiabetic Tablet, Blood Sugar Control Medicine, Diabetes Combination Therapy, Oral Diabetes Medication, Glucose Lowering Tablet, Prescription Diabetes Medicine, Kidney Support Diabetes Therapy, Metabolic Health Medicine, OXRA MET Tablet.